The effects of suberythematous levels of UV-B radiation on the development of cutaneous leishmaniasis were studied in B10.129(10M) mice. Doses of 15 mJ cm2 UV-B applied locally to the injection site suppressed the development of skin lesions after the inoculation of Leishmania major promastigotes. The primary targets of UV-B radiation appeared to be host cells and not leishmanial parasites, because UV-B irradiation of parasites cultured in vitro did not affect their viability, but did kill host cells. Furthermore, the same numbers of parasites were recovered from skin at the in,ection site in both irradiated and control mice. UV-B irradiation abrogated the induction of contact hypersensitivity to dinitrofluorobenzene and also abrogated the induction of delayed-type hypersensitivity responses to leishmanial antigens. These results suggest that local perturbations in the functions of the skin-associated lymphoid tissue during the initial phases of leishmanial infection can profoundly influence immunological response and the subsequent development of clinical disease.
Cutaneous leishmaniasis results from infection by organisms of the Leishmania species, obligate intracellular protozoan parasites of macrophages, monocytes, and histiocytes. Leishmania species are transmitted by phlebotomine flies (sandflies). Depending on the species of Leishmania, infection may result in a broad spectrum of cutaneous diseases, encompassing asymptomatic infection, transient induration, a self-limiting skin ulcer (Oriental sore), nonhealing skin lesion (leishmaniasis recidivans), metastasis to distal skin sites (incurable diffuse cutaneous leishmaniasis), or metastasis to the mucocutaneous junctions (nonhealing espundia or mucocutaneous leishmaniasis).
Little is known about the development of pathology during the cutaneous phase of leishmaniasis. Certainly the immunogenetic background of the host is a major factor in the response to cutaneous leishmanial infection. Certain ethnic groups of humans are more susceptible than others to mutilating lesions of mucocutaneous leishmaniasis (31) and to leishmaniasis recidivans (14) . In mice, the sequelae to leishmanial infections are characteristic for each inbred strain (3, 5, 7, 8, 15, 16 ). Yet not all infected individuals in groups at high risk for these sequelae develop severe disease. Thus, other factors are probably involved.
Cutaneous leishmaniasis in humans generally occurs on parts of the body that are naturally exposed both to the bites of sandflies and to solar radiation. UV light in the sunburn portion of the spectrum, 280 to 320 nm (herein referred to as UV-B), is known to have profound effects on the immune system (reviewed in references 4, 9, 17, 20, and 27) . The purpose of this study was to determine whether local perturbations in the function of the skin-associated lymphoid tissue (28) during the initial phases of leishmanial infection would influence the development of cutaneous disease.
MATERIALS AND METHODS
Parasites. Leishmania major (Leishmania tropica major) strain WR300 promastigotes were used throughout. The history of the strain and methods of maintenance, enumeration, cultivation, and harvest have been described elsewhere (lla).
Hosts. Male and female BALB/cJ mice and male B10.129(10M) ScSn mice (25) (Jackson Laboratory, Bar Harbor, Maine) were sex and age matched and used for experiments between 1 and 4 months of age. The B10.129(10M) strain is chronically susceptible to visceral leishmaniasis (8) , unlike most other inbred strains, and relatively resistant to cutaneous leishmaniasis (7) . Females are much more susceptible than males, however (S. H. Giannini, Parasite Immunol., in press). BALB/c mice are highly susceptible to cutaneous leishmaniasis, developing expanding skin ulcers with fatal metastases to distal skin sites and internal lymphoid organs (16) .
J774A.1 cell line. J774A.1, a macrophagelike cell line of BALB/c origin (23) , was obtained from the American Type Culture Collection (Rockville, Md.) and maintained at 35°C as described by Chang (6) .
UV-B irradiation source. Mice or cultures were irradiated with a Waldmann UV800 UV-B source (Schwenningen, Federal Republic of Germany) equipped with six Phillips TL 20W/12 UV-B bulbs. Output was monitored with an IL-782 spectroradiometer (International Light, Newburyport, Mass.). The peak output of the light source was at 300 nm, with 79% of the UV output occurring between 280 and 320 nm (the remaining output occurred at wavelengths >320 nm). The flux was 1.33 mW cm-2, and the time to deliver 15 mJ cm-2 was 12 s.
UV irradiation of mice. Mice were restrained in plastic holders, and their tails were immobilized with tape at their tips. The dorsal surfaces of their tails were irradiated, whereas their bodies were shielded with aluminum foil. To control for heat and stress induced by handling, unirradiated control mice were similarly restrained, but both their bodies and tails were shielded from the UV light source.
Effect of UV-B on the induction of contact hypersensitivity.
Mice were shielded or irradiated on their tails with 60 or 15 mJ of UV-B per cm2 (described above), sensitized 24 h after irradiation, and challenged after 5 days with dinitrofluorobenzene (DNFB) as described previously (29 (1, 29) .
Assessment of lesion pathology. The extent of lesion development was recorded weekly for infected mice. As a semiquantitative measure of pathology, each category of cutaneous lesion appearance was assigned a numerical value. The indices of pathology and the lesions they represented were as follows: 1, no lesion or healed lesion; 2, nodule or swelling (5-mm diameter); 3, small ulcer, the diameter of the nodule; 4, expanding ulcer (larger than the nodule, diameter >5 mm); 5, tail loss or metastatic skin lesion; 6, death.
In some mice, a small depigmented macule 1 to 5 mm in diameter was observed at the injection site. Such depigmentation in the absence of induration was also scored as 1, because depigmented areas on the tail were present in uninfected B10.129(10M) mice.
UV Table 2 . Cultures were irradiated or shielded and infected 24 h later with L. major promastigotes in a ratio of five promastigotes per host cell. Cells were irradiated again at 24 and at 72 h after infection; controls were shielded. Cells were harvested 48 h after the last irradiation.
Petri dishes containing J774A.1 cells were gently washed three times to remove nonadherent cells and free parasites. The host cells per 1-cm2 area of the petri dish were counted by using an inverted microscope fitted with a calibrated ocular grid. Four representative fields per plate were counted at x256 magnification. Cells were then suspended with a rubber policeman in 4 ml of medium. Cytospin preparations were made (Shandon Southern Instruments, Inc., Sewickley, Pa.), fixed in absolute methanol, and Giemsa stained. The ratio of parasites per host cell was then determined microscopically at x 1,000 magnification.
Determination of the viability of leishmanias after UV-B irradiation. For in vitro experiments, infected irradiated J774A.1 cells and infected unirradiated controls were suspended as described above.
For in vivo experiments, tail skin surrounding the injection site was removed (-1.5-cm length) and triturated in 0. (20) and is less than the amount of UV-B radiation in 1 h of exposure to sunlight on a bright day at noon (11) .
With the lower dose of UV-B which suppressed sensitization of mice to DNFB, the development of cutaneous leishmaniasis in a relatively resistant host, the B10.129(10M) male, was indeed affected (Fig. 1) . Surprisingly, lesion development was suppressed in irradiated mice. As early as 2 months postinfection, most of the irradiated mice had no lesions, whereas control mice were well on their way to ulceration ( Fig. 1) (P < 0.01).
Lack of effect of UV-B on parasite viability. To determine whether UV-B directly damaged the parasites, the J774A.1 cell line, infected with L. major promastigotes, was irradiated on a schedule similar to that used for the mice. Radiation did not reduce the numbers of leishmania per host cell in infected cultures. However, the number of host cells in cultures irradiated with 15 mJ cm-2 was reduced, compared with unirradiated or untreated controls ( Table 2) .
The lack of a parasiticidal effect of UV-B was further confirmed in vivo. In two experiments, the numbers of parasites recovered from irradiated injection sites were not significantly different than from shielded controls ( Table  3) .
Taken together, these results suggest that the primary effect of UV irradiation is on the host cell.
Long-term effect of UV-B irradiation at inoculation site. In a second in vivo experiment, the development of lesion pathology was followed for 5 months after the final UV irradiation, for a total of 6 months. A progressive dichotomy in the severity of lesions in the control and irradiated mice was clearly present (Fig. 2) , evidence of a long-lasting effect of early immunological events on subsequent development of pathology.
Suppression of lesion development despite presence of parasites in skin. To determine whether the reduced lesion development in the UV-B-irradiated groups might result from the killing of potential host cells and hence reflect an absence of parasites, leishmanias were sought in skin ey cised from the injection site. Despite highly significant reductions in lesion pathology (P < 0.01), the skin was infected in 100% of animals, even those with no discernible bDetermined by culturing serial 10-fold dilutions as described previously (la). c NS, Not significant.
lesions (Table 4 ). These results show that the suppression of lesion development induced by UV-B irradiation does not indicate an absence of leishmanias. Absence of DTH response to leishmanial antigens in UV-B irradiated mice. Because UV-B irradiation of the site of application of antigen was able to suppress the development of contact hypersensitivity to DNFB, the effect of UV-B irradiation on the animals' subsequent ability to mount a DTH response to parasite antigens was tested in a third in vivo experiment. At 2 and 6 weeks after infection, irradiated mice challenged intradermally with leishmanial antigens showed minimal DTH responses, compared with the unirradiated controls (Table 5) .
DISCUSSION
This study was designed to investigate whether low doses of UV-B at the inoculation site at the time of infection could influence the subsequent development of clinical disease in cutaneous leishmaniasis. It is important to note that the effective dose of radiation used here, 15 mJ cm-2, is well below the minimum erythematous dose of 40 mJ cm2 (20) and is the minimal amount of radiation shown by others selectively to damage Langerhans cells (1) . This dose is considerably lower than those used in earlier studies of suppression of contact hypersensitivity by UV-B irradiation (4, 9, 10, 27, 29) . Low levels of UV-B irradiation, similar to those used in the present study, would likely be encountered '*Significantly lower than unirradiated control (P < 0.01). dControl for the effect of L. major parasites on growth of host cells; cultures were not infected. by populations at risk for leishmaniasis, especially rural populations.
A single dose of 15 mJ cm2 abrogated the development of contact hypersensitivity in B10.129(10M) mice, but not in BALB/c mice (Table 1) . That BALB/c mice (as well as some other strains) are radiation resistant has been shown by others (4) . Consistent with this, UV-B irradiation does not affect lesion development in BALB/c mice (data not shown). Contrary to what might be expected, radiation resistance, which varies among strains of mice, is not correlated with skin pigmentation (4) . We might then predict that any effects of UV-B on the functioning of the skin-associated lymphoid tissue in humans need not be race specific, but rather might reflect the workings of some other genetic polymorphism.
Several conclusions may be drawn from this study. Of particular significance is the finding that the absence of a skin lesion need not (1, 29) , primed T cells (19) , and keratinocytes (2, 24) , whereas T suppressor cells are relatively resistant and may even be induced by UV-B irradiation in vivo (10, 12, 13) . The identity of the particular host cell type(s) affected remains to be elucidated by further studies in vitro, now in progress.
Protective immunity in leishmaniasis is cell mediated (21, 22, 26) , and a DTH response to leishmanial antigens is generally considered indicative of the onset of healing. However, it has recently been shown that murine cutaneous leishmaniasis is exacerbated by adoptive transfer of helper T cells which mediate Leishmania-specific DTH (30), whereas protection against murine leishmaniasis is transferred by Lyt-1+2-cells that do not mediate a cutaneous DTH (18) . Certainly in human infections, both mucocutaneous leishma- (Fig. 1 and 2 
